US policy regarding drug pricing is creating delays for medicine launches in Europe, impacting global access.

1 report, 1 independent Updated Sep 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Donald Trump ETH Zurich

Keep exploring

Part of

The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.

Also in this story

The Trump administration launched a Section 301 investigation into foreign countries setting artificially low drug prices.Aug 27

All 3 developments

The entities involved

Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Trump ended the ceasefire agreement with Iran following recent attacks by Iranian forces.Mon 18:02
- The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02
ETH Zurich
public research university in Zurich
- ETH Zurich provides expert analysis on heat, while Switzerland debates air conditioning policies modeled after Germany and France.Mon 08:27
- Research teams from ETH Zurich and Agroscope studied cheese.Fri 09:51

Related events

Roberta Metsola advised Germany to seek a deal with the Trump administration amid an ongoing drug pricing trade dispute.Thu 21:32

Coverage

Newest first; wire copies grouped

Sep 14euronews.com